ARID1A and pancreatic neoplasm: also found that ARID1A deficiency, together with KRAS-G12D mutation, drive the development of pancreatic cancer via miR-503/CDKN2A axis-mediated senescence, although how ARID1A affects miR-503 transcription is not clear (71).